About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Breast Reconstruction Need Not be Delayed Due to Trastuzumab Therapy

by Anjali Aryamvally on October 6, 2017 at 9:41 PM
Font : A-A+

Breast Reconstruction Need Not be Delayed Due to Trastuzumab Therapy

Treatment of breast cancers that express HER-2 protein with trastuzumab (Herceptin/Genentech) is not a risk factor for complications at the surgical site in women who undergo immediate breast reconstruction after mastectomy. In a first study of its kind, the research team indicates that breast reconstruction need not be delayed because of the type or length of adjuvant therapy using trastuzumab. The study will be published in the Journal of the American College of Surgeons and appears as an "article in press" on the website in advance of print.

Adjuvant therapy using trastuzumab and pertuzumab

Advertisement


Adjuvant therapy is treatment that is given in addition to the primary or main form of treatment to maximize effectiveness. While trastuzumab therapy does not increase risk, combination therapy involving trastuzumab and pertuzumab (Perjeta/Genentech) may carry an increased risk for wound complications after immediate breast reconstruction. Therefore, authors of the study advise surgeons and patients to consider delaying breast reconstruction in otherwise high-risk patients until completion of the full course of treatment if pertuzumab is added to the neoadjuvant regimen. "If a patient is otherwise fairly healthy and the surgery is straightforward, immediate breast reconstruction may be done even if she is receiving both therapies. If a patient has other risk factors and faces a potentially difficult operation, I would recommend waiting until the completion of pertuzumab therapy," said Scott Hollenbeck, MD, FACS, principal author of the study and a plastic and reconstructive surgeon at Duke University Medical Center, Durham, N.C.

Twenty percent of invasive breast cancers have tumors that express the growth factor protein HER-2. These tumors tend to grow and spread more rapidly than other forms of breast cancer. Trastuzumab is a monoclonal antibody that targets the HER-2 protein. When given in conjunction with conventional chemotherapy, trastuzumab has increased overall survival, 10-year survival, and disease-free survival of patients with HER-2+ breast cancer.
Advertisement

Pertuzumab is also used in the treatment of HER-2+ breast tumors. The monoclonal antibody was approved in 2012 for combination therapy with trastuzumab to treat the small number of patients with HER-2-expressing tumors that have metastasized, were larger than 2 cm, involved lymph nodes, or were inflammatory or locally advanced. The addition of pertuzumab to trastuzumab and chemotherapy has prolonged survival for patients with metastatic disease.

Breast reconstruction after mastectomy

The concern for surgeons who perform breast reconstruction after mastectomy is whether suppression of the HER-2 protein affects the integrity of the skin and therefore increases a patient's susceptibility for wound infection or breakdown at the surgical site. "During surgical reconstruction of the breast after mastectomy, the skin is saved and an implant or flap is inserted underneath. If the skin doesn't heal or dies, the reconstruction could fail and require another operation. Trastuzumab and pertuzumab block the action of HER-2, which is associated with the epidermis or outer layer of the skin. Up to now, there haven't been any studies of the outcomes after breast reconstruction in patients who received these agents. We conducted this study to determine whether trastuzumab alone or in combination with pertuzumab negatively affected breast reconstruction outcomes," Dr. Hollenbeck said.

Investigators at Duke University identified all patients who had breast reconstruction after mastectomy between 2006 and 2016. Of the total of 481 women, the researchers compared outcomes in two matched groups of 107 patients. One group received trastuzumab with or without pertuzumab; the other did not. Patients were matched by age, obesity, diabetes, tobacco use, and type of oncologic treatment regimen.

Overall, the rate of wound breakdown that required a return to surgery for treatment was higher in patients who received both trastuzumab and pertuzumab. The use of trastuzumab alone was not associated with any complication at the surgical site, including bleeding, swelling, coagulation or clotting, disruption of the layers of skin around the surgical incision, or cellular death in the mastectomy skin flap.

"At the present time, there are no clear clinical guidelines on the optimal timing for breast reconstruction. While preliminary, this study may be helpful for guiding the decision by patients and surgeons," Dr. Hollenbeck said.

Findings from the study need to be validated in larger, prospective studies. Until then, the study results may help surgeons feel more comfortable performing immediate breast reconstruction on patients who receive trastuzumab and delaying the surgery for those on combination targeted HER-2 treatment," he concluded.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Mastitis Reiki and Pranic Healing Breast Augmentation Breasts - Structures and Types Breast Lumps Breast Lumps-Screening Male Breast Cancer Breast Enhancement Oil Flap Surgery 

Recommended Reading
Trastuzumab Better Than Lapatinib in HER-2 Positive Breast Cancer
Trastuzumab, when used in neoadjuvant chemotherapy along with other medications in HER-2 positive .....
Breast Cancer Drug Rejected for NHS Use Due to High Costs
Trastuzumab emtansine drug for breast cancer is rejected for National Health Services (NHS) use in ....
Fat Grafting for Postmastectomy Breast Reconstruction Examined
Breast reconstruction is surgery to make a new breast after removal of the breast or part of the ......
Delaying Breast Reconstruction Following Mastectomy may Benefit Some Women
Patients with a combination of risk factors, such as being obese and having diabetes or being a ......
Breast Augmentation
Losing sleep over the size of your breasts? Then wake up to breast enlargement! Consult us our spec...
Breast Enhancement Oil
Breasts contain mammary glands which produce and secrete milk for feeding and nourishing babies. Tho...
Breast Lumps
Most breast lumps are caused by hormonal changes in a woman and may not be cancerous. Common causes ...
Breast Lumps-Screening
Breast lumps must never be neglected but instead be subjected to medical examination to rule out ......
Breasts - Structures and Types
Different stages of breast development in women and an in-depth look at the breast/bust and its ......
Male Breast Cancer
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of mal...
Mastitis
Mastitis is a common cause of tenderness, swelling and pain in breast, owing to inflammation in the ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use